Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 19 Adrenergic-Blocking Drugs.

Slides:



Advertisements
Similar presentations
Cardiovascular and Renal Medications
Advertisements

Antiarrhythmic Agents: Cardiac Stimulants and Depressants
Adrenergic-Blocking Drugs
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 24 Antianginal Drugs.
Adrenergic & Adrenergic-blocking Agents
Chapter 5 Autonomic Drugs.
Alpha-Adrenergic Blockers
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 18 Adrenergic Antagonists.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 18 Adrenergic-Blocking Drugs.
Chapter 18 Agents that Dilate Blood Vessels. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Coronary.
Adrenoceptor Blockers
ADRENERGIC ANTAGONITS
Autonomic Nervous System
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 18 Adrenergic Drugs.
Chapter 17 Cardiac Stimulants and Depressants. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved
Adrenergic antagonist sympatholytic
DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM 10/8/2015Winter
Adrenergic Blocking Drugs
Agents that Dilate Coronary Blood Vessels.  Coronary artery disease (CAD) results from atherosclerosis  Clinical symptoms caused by  narrowing of the.
ANTI-ADRENERGIC DRUGS
HuBio 543 September 27, 2007 Neil M. Nathanson K-536A, HSB
Copyright © 2011 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 13 Autonomic Nervous System Drugs.
Bronchodilators Lilley Pharmacology Text: Chapter 35
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 21 Positive Inotropic Drugs.
Drugs Affecting Blood Pressure Brenda B. Rowe. Vasopressors Treat shock Treat shock Dopamine (Intropin) – stimulates alpha-1 & beta-1 Dopamine (Intropin)
Chapter 33 Agents Affecting the Autonomic Nervous System.
Adrenergic agemts. Learning Objectives Understand the central and peripheral nervous systems, their functions, and their relationship to drugs. Become.
Slide 1 Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 13 Drugs Affecting the Autonomic Nervous System.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 17 Adrenergic Drugs.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 19 Cholinergic Drugs.
Adrenergic Receptor Antagonists Excessive sympathetic activity is characteristic of a number of pathological states including: Hypertension Angina pectoris.
 Cardiovascular Effects  α -receptor antagonist drugs lower peripheral vascular resistance and blood pressure.  These drugs can prevent the pressor.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 46 Vasodilators.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 20 Cholinergic Drugs.
Diuretics and Antihypertensives
Adrenergic agemts. Learning Objectives Understand the central and peripheral nervous systems, their functions, and their relationship to drugs. Become.
- If other drug therapies do not achieve the desired reduction in blood pressure, it is sometimes necessary to use a direct vasodilator. - Most of the.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 23 Antianginal Drugs.
بسم الله الرحمن الرحيم.
Cardiac Stimulants and Depressants
PHARMACOLOGY OF ANS part 3 General Pharmacology M212
Adrenergic Antagonists
ANS True or False Rationale. If I were admitted with decreased circulation to my toes which are blue and painful, you would give me an alpha blocker.
Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. 1 Chapter 18 ADRENERGIC AGONISTS AND ADRENERGIC BLOCKERS.
Phenylephrine Phenylephrine Phenylephrine is a direct-acting, synthetic adrenergic drug that binds primarily to α receptors ( favors α 1 receptors over.
Adrenergic Receptor Antagonists These are drugs which antagonize α or β or both α and β adrenergic receptors Adrenergic neurone blocking agents (Sympatholytic)
Adrenergic Agonists and Adrenergic Blockers
1 Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. Chapter 42 CARDIAC GLYCOSIDES, ANTIANGINALS, AND ANTIDYSRHYTHMICS.
Adrenergic Antagonists (Sympatholytics). Basic stages in synaptic transmission.
1 ADRENERGIC ANTAGONITS. 2 ADRENERGIC BLOCKERS ALPHA BLOCKERS Alpha 1 Blockers Nonselective Alpha Blockers Doxazosin Phenoxybenzamine Prazosin Phentolamine.
Sympatholytic & adrenergic blockers -receptor Antagonists
Adrenergic Antagonists
Drugs Used to Treat Dysrhythmias
Drugs Affecting Autonomic Nervous System 1
Sympatholytic & adrenergic blockers -receptor Antagonists
Drugs Affecting The Autonomic Nervous System
Sympatholytic & adrenergic blockers -receptor Antagonists
Antihypertensive Agents
Drugs Used to Treat Hypertension
Sympatholytic & adrenergic blockers -receptor Antagonists
Drugs for Autonomic Nervous System
β – ADRENERGIC BLOCKERS
Alpha-Adrenergic Blocking Drugs: Actions and Uses
Characteristics of Adrenergic Drugs (p. 291)
Beta-adrenergic blocking agents
Adrenergic agonists and antagonists
CHAPTER 18 Adrenergic-Blocking Drugs
Sympatholytic & adrenergic blockers -receptor Antagonists
Adrenergic Antagonist
Drugs Affecting Blood Pressure
Presentation transcript:

Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 19 Adrenergic-Blocking Drugs

2 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Adrenergic Blockers  Bind to adrenergic receptors, but inhibit or block stimulation of the sympathetic nervous system (SNS)  Alpha-blockers and beta-blockers

3 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Adrenergic Blockers (cont’d)  Have the opposite effect of adrenergic drugs  Inhibit—or lyse—sympathetic stimulation  Also known as:  Adrenergic antagonists  Sympatholytics  Alpha-blockers, beta-blockers, or alpha-beta blockers

4 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Adrenergic Blockers (cont’d)  Classified by the type of adrenergic receptor they block  Alpha 1 and alpha 2 receptors  Beta 1 and beta 2 receptors

5 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.

6 Drug Effects and Indications: Alpha-Blockers  Cause both arterial and venous dilation, reducing peripheral vascular resistance and BP  Used to treat hypertension  Effect on receptors on prostate gland and bladder decreases resistance to urinary outflow, thus reducing urinary obstruction and relieving effects of BPH

7 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Drug Effects and Indications: Alpha-Blockers (cont’d)  Used to control and prevent hypertension in patients with pheochromocytoma  Phentolamine  Quickly reverses the potent vasoconstrictive effects of extravasated vasopressors such as norepinephrine or epinephrine  Restores blood flow and prevents tissue necrosis

8 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Alpha-Blockers: Adverse Effects Body SystemAdverse Effects CardiovascularPalpitations, orthostatic hypotension, tachycardia, edema, dysrhythmias, chest pain CNSDizziness, headache, drowsiness, anxiety, depression, vertigo, weakness, numbness, fatigue

9 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Alpha-Blockers: Adverse Effects (cont’d) Body SystemAdverse Effects GastrointestinalNausea, vomiting, diarrhea, constipation, abdominal pain OtherIncontinence, nosebleed, tinnitus, dry mouth, pharyngitis, rhinitis

10 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Common Alpha-Blockers  phenoxybenzamine HCl (Dibenzyline)  phentolamine (Regitine)  prazosin (Minipress)  tolazoline (Priscoline)

11 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Beta-Blockers  Block stimulation of beta receptors in the SNS  Compete with norepinephrine and epinephrine  Can be selective or nonselective  Nonselective beta-blockers block both beta 1 and beta 2 receptors

12 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Beta Receptors  Beta 1 receptors  Located primarily on the heart  Beta-blockers selective for these receptors are called cardioselective beta-blockers  Beta 2 receptors  Located primarily on smooth muscle of bronchioles and blood vessels

13 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Mechanism of Action  Cardioselective beta-blockers (beta 1 )  Reduce SNS stimulation of the heart  Decrease heart rate  Prolong SA node recovery  Slow conduction rate through the AV node  Decrease myocardial contractility, thus reducing myocardial oxygen demand

14 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Mechanism of Action (cont’d)  Nonselective beta-blockers (beta 1 and beta 2 )  Cause same effects on heart as cardioselective beta-blockers  Constrict bronchioles, resulting in narrowing of airways and shortness of breath  Produce vasoconstriction of blood vessels  Other effects

15 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Indications  Angina  Decreases demand for myocardial oxygen  Cardioprotective  Inhibits stimulation from circulating catecholamines  Dysrhythmias  Class II antidysrhythmic  Migraine headache  Lipophilicity allows entry into CNS

16 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Indications (cont’d)  Antihypertensive  Heart failure  Glaucoma (topical use)

17 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Adverse Effects: Beta-Blockers Body SystemAdverse Effects BloodAgranulocytosis, thrombocytopenia CardiovascularAV block, bradycardia, heart failure, peripheral vascular insufficiency CNSDizziness, mental depression, lethargy, hallucinations, unusual dreams

18 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Adverse Effects: Beta-Blockers Body SystemAdverse Effects GastrointestinalNausea, dry mouth, vomiting, diarrhea, cramps, ischemic colitis OtherImpotence, rash, alopecia, bronchospasm

19 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Adverse Effects: Beta-Blockers  Nonselective beta-blockers may interfere with normal responses to hypoglycemia (tremor, tachycardia, nervousness)  May mask signs and symptoms of hypoglycemia

20 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Beta-Blockers: Examples  acebutolol (Sectral)  carvedilol (Coreg)  labetalol (Normodyne)  metoprolol (Lopressor)  atenolol (Tenormin)  esmolol (Brevibloc)  sotalol (Betapace)  propranolol (Inderal)

21 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Adrenergic-Blocking Drugs: Nursing Implications  Assess for allergies and history of COPD, hypotension, cardiac dysrhythmias, bradycardia, heart failure, or other cardiovascular problems  Any preexisting condition that might be exacerbated by the use of these drugs might be a contraindication to their use

22 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Adrenergic-Blocking Drugs: Nursing Implications (cont’d)  Remember that alpha-blockers may precipitate hypotension  Remember that some beta-blockers may precipitate bradycardia, hypotension, heart block, heart failure, and bronchoconstriction

23 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Adrenergic-Blocking Drugs: Nursing Implications (cont’d)  Avoid over-the-counter medications because of possible interactions  Possible drug interactions may occur with:  Antacids (aluminum hydroxide type)  Antimuscarinics/anticholinergics  Diuretics and cardiovascular drugs  Neuromuscular blocking drugs  Oral hypoglycemic drugs

24 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Adrenergic-Blocking Drugs: Nursing Implications (cont’d)  Encourage patients to take medications as prescribed  Instruct patients that these medications should never be stopped abruptly  Inform patients to report constipation or the development of urinary hesitancy or bladder distention

25 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Adrenergic-Blocking Drugs: Nursing Implications (cont’d)  Teach patients to change positions slowly to prevent or minimize postural hypotension  Instruct patients to avoid caffeine (excessive irritability)  Instruct patients to avoid alcohol ingestion and hazardous activities until blood levels become stable  Instruct patients to notify their physician if palpitations, dyspnea, nausea, or vomiting occurs

26 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Adrenergic-Blocking Drugs: Nursing Implications (cont’d)  Monitor for adverse effects  Monitor for therapeutic effects  Decreased chest pain in patients with angina  Return to normal BP and HR  Other specific effects, depending on the use

27 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Beta-Blocking Drugs: Nursing Implications  Rebound hypertension or chest pain may occur if this medication is discontinued abruptly  Instruct patients to notify their physician if they become ill and unable to take medication  Inform patients that they may notice a decrease in tolerance for exercise (dizziness and fainting may occur with increased activity), and have patients notify the physician if these problems occur

28 Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Beta-Blocking Drugs: Nursing Implications (cont’d)  Inform patients to report the following to their physician:  Weight gain of more than 2 pounds in 1 day or 5 pounds in 1 week  Edema of the feet or ankles  Shortness of breath  Excessive fatigue or weakness  Syncope or dizziness